These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35130795)

  • 1. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel.
    Wang L; Chen H; Wang F; Zhang X
    Expert Opin Drug Deliv; 2022 Feb; 19(2):147-161. PubMed ID: 35130795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer.
    Duan Z; Chen C; Qin J; Liu Q; Wang Q; Xu X; Wang J
    Drug Deliv; 2017 Nov; 24(1):752-764. PubMed ID: 28468542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide cargo administration: current state and applications.
    Rohira H; Arora A; Kaur P; Chugh A
    Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide Drug Conjugates and Their Role in Cancer Therapy.
    Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Antiproliferative Activities of Conjugates of Paclitaxel and Camptothecin with a Cyclic Cell-Penetrating Peptide.
    El-Sayed NS; Shirazi AN; Sajid MI; Park SE; Parang K; Tiwari RK
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30978971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source and exploration of the peptides used to construct peptide-drug conjugates.
    Zhou J; Li Y; Huang W; Shi W; Qian H
    Eur J Med Chem; 2021 Nov; 224():113712. PubMed ID: 34303870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
    Alas M; Saghaeidehkordi A; Kaur K
    J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment.
    Deng X; Mai R; Zhang C; Yu D; Ren Y; Li G; Cheng B; Li L; Yu Z; Chen J
    Eur J Med Chem; 2021 Mar; 213():113050. PubMed ID: 33280896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
    Paulus J; Sewald N
    J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
    Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance.
    Dai Y; Cai X; Bi X; Liu C; Yue N; Zhu Y; Zhou J; Fu M; Huang W; Qian H
    Eur J Med Chem; 2019 Jun; 171():104-115. PubMed ID: 30913525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legumain/pH dual-responsive lytic peptide-paclitaxel conjugate for synergistic cancer therapy.
    Zheng S; Cai Y; Hong Y; Gong Y; Gao L; Li Q; Li L; Sun X
    Drug Deliv; 2022 Dec; 29(1):1764-1775. PubMed ID: 35638851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
    Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
    Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
    Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
    Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
    Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles of paclitaxel and cyclodextrin-polypeptide conjugates with
    Yusheng S; Chenjun M; Yingying H; Tiantian W; Liefeng Z
    Pharm Dev Technol; 2020 Nov; 25(9):1071-1080. PubMed ID: 32589088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.